Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

(MedPage Today) — A higher and less frequent dose of aflibercept (Eylea) was noninferior to the standard dose for the treatment of polypoidal choroidal vasculopathy (PCV) in patients with neovascular (“wet”) age-related macular degeneration (AMD…

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119109

Author :

Publish date : 2025-12-19 18:27:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

Convenience Is Quietly Undermining Physician Autonomy

‘Rotten Tomatoes’ for FDA, Pharma; Cancer Trial Halted; Cooked Food Tops Fresh

Related Posts

No-one knows what to expect when you’re dying – but hospices helped me

Air Ambulance Care Varies Widely Across the UK, Audit Finds

Three quarters will survive cancer by 2035, government promises

No Clear Winner for Pump vs No-Pump CABG, Choice of MABG Arterial Conduits

Healthcare Workers Still Not Exempt From H-1B Visa Fee

Almost 40% of Cancers Worldwide Linked to Modifiable Risk Factors

No-one knows what to expect when you’re dying – but hospices helped me

Air Ambulance Care Varies Widely Across the UK, Audit Finds

Three quarters will survive cancer by 2035, government promises

No Clear Winner for Pump vs No-Pump CABG, Choice of MABG Arterial Conduits

Healthcare Workers Still Not Exempt From H-1B Visa Fee

Almost 40% of Cancers Worldwide Linked to Modifiable Risk Factors

NIH Chief Details Plans for FDA Modernization at Senate Hearing

House Lawmaker Raises New Concerns Over FDA’s Ultra-Fast Drug Review Program

Categories

Archives